MTCR Market Cap History Table | ||||||||||||||||||||||
Also see: MTCR Shares Outstanding History and MTCR YTD Return |
MTCR Market Cap History Table | ||||||||||||||||||||||
Also see: MTCR Shares Outstanding History and MTCR YTD Return |
MTCR Market Cap History Chart | ||||||||||||||||||||||||||||||
-74.20% CAGR Mouse over chart for data details
|
MTCR Stock Price Chart |
About Metacrine Inc |
Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with gastrointestinal, or GI, diseases. Co.'s program, MET642, targets the farnesoid X receptor, or FXR, which is central to modulating GI and liver diseases. Co. is developing another FXR agonist, MET409, for the treatment of non-alcoholic steatohepatitis, or NASH, a liver disease characterized by excess liver fat, inflammation and fibrosis. Co. is also developing small molecule inhibitors of hydroxysteroid dehydrogenase 17b13, or HSD17ß13, for the treatment of NASH. HSD17ß13 is a genetically validated target for liver disease. We show 10 historical shares outstanding datapoints in our MTCR shares outstanding history coverage, used to compute MTCR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MTCR market cap history over the course of time is important for investors interested in comparing MTCR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MTCR versus a peer is one thing; comparing MTCR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MTCR can fluctuate over the course of history. With this page we aim to empower investors researching MTCR by allowing them to research the MTCR market cap history. |
MTCR Current Stock Quote |
Free MTCR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MTCR Share Performance |
Market Cap Peers |
Metacrine (MTCR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MTEM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.